Hydroxocobalamin is a synthetic form of vitamin B12 used to treat deficiencies and cyanide poisoning. It plays a critical role in red blood cell formation, DNA synthesis, and neurological function. This article explores its chemical properties, mechanisms, clinical applications, and safety profile.
Chemical Structure
Hydroxocobalamin has the molecular formula C62H90ClCoN13O15PC62H90ClCoN13O15P and a molecular weight of 1,382.82 g/mol. Its structure includes a cobalt-centered corrin ring linked to a benzimidazole group and a hydroxyl ligand. The compound appears as a dark brown to black solid, soluble in methanol, and is hygroscopic.
Mechanism of Action
As a vitamin B12 analog, hydroxocobalamin serves as a precursor to two coenzymes:
- Methylcobalamin: Facilitates the conversion of homocysteine to methionine, essential for folate metabolism and DNA synthesis.
- Adenosylcobalamin: Converts methylmalonyl-CoA to succinyl-CoA, critical for lipid and carbohydrate metabolism.
In cyanide poisoning, hydroxocobalamin binds cyanide ions (CN−CN−) to form nontoxic cyanocobalamin, restoring mitochondrial oxidative metabolism. Approximately 52 g of hydroxocobalamin neutralizes 1 g of cyanide.
Pharmacokinetics
- Absorption: Achieves higher serum concentrations via intramuscular injection compared to oral administration.
- Protein Binding: 90% bound to plasma proteins, primarily transcobalamin II.
- Half-Life: Approximately 6 days, with storage primarily in the liver.
- Elimination: Excreted renally, with minimal metabolism required for activation.
Therapeutic Uses
- Vitamin B12 Deficiency:
- Treats pernicious anemia (autoimmune destruction of gastric parietal cells).
- Addresses deficiencies caused by metformin therapy, vegan diets, or malabsorption.
- Initial regimen: 1 mg intramuscular injections daily, tapering to monthly maintenance.
- Cyanide Poisoning:
- Administered intravenously in emergencies (e.g., smoke inhalation, chemical exposure).
- Other Indications:
- Leber’s optic atrophy, tobacco amblyopia, and methylmalonic acidemia.
Hydroxocobalamin-Based Medicines
Several well-known medicines and branded formulations use hydroxocobalamin as their active pharmaceutical ingredient (API). These are primarily indicated for the treatment of vitamin B12 deficiency and cyanide poisoning. Below is a list of notable medicines containing hydroxocobalamin:
- Cyanokit: This is a widely recognized intravenous formulation specifically approved for the emergency treatment of cyanide poisoning. It is available as a lyophilized powder for reconstitution and intravenous administration.
- Cobalin-H: This brand is used for intramuscular injection to treat vitamin B12 deficiency, including pernicious anemia and other macrocytic anemias. It is also indicated for conditions like Leber’s optic atrophy and tobacco amblyopia.
- Neo-Cytamen: Another common brand used for vitamin B12 replacement therapy, particularly in cases of deficiency due to malabsorption or dietary insufficiency.
- Hydro-Cobex: This is an injectable form of hydroxocobalamin used primarily for vitamin B12 deficiency and related disorders.
- Generic Hydroxocobalamin Injections: These are available from multiple manufacturers and are used for both intramuscular and intravenous administration in the treatment of B12 deficiency and cyanide poisoning.
- Aronamin Gold: This is a combination oral tablet containing hydroxocobalamin acetate along with other vitamins, used as a multivitamin supplement.
- NOROGRİZOVİM I.M.: This is a combination injectable solution containing hydroxocobalamin and other B vitamins, used for deficiency states.
These medicines are available in various countries and may be marketed under different brand names depending on the region and manufacturer. The most prominent and internationally recognized brands are Cyanokit (for cyanide poisoning) and Cobalin-H (for B12 deficiency)
Side Effects
Common adverse effects include:
- Gastrointestinal: Nausea, diarrhea.
- Injection-site reactions: Pain, swelling, itching.
- Rare systemic effects: Hypokalemia, allergic reactions, hypertension.
Drug Interactions
- Metformin: Chronic use may exacerbate B12 deficiency.
- Chloramphenicol: May reduce erythrocyte response to hydroxocobalamin.
Safety Considerations
- Pregnancy: No evidence of teratogenicity; considered safe.
- Long-Term Use: Well-tolerated, with lifelong therapy required for chronic deficiency states.
- Monitoring: Serum B12 levels, hematological parameters, and potassium levels during cyanide treatment.
Regulatory Status
Hydroxocobalamin is prescription-only in most jurisdictions. It is listed on the WHO Model Lists of Essential Medicines List and approved by regulatory agencies for both hematological and toxicological indications. Oral formulations exist but show lower efficacy compared to parenteral routes in severe deficiency.
Hydroxocobalamin remains a cornerstone therapy for B12-related disorders and acute cyanide toxicity, with a well-characterized safety profile spanning decades of clinical use.
